Michelle Fransen Shares A Historical Review on Plasma-Derived Medicinal Products
Michelle Fransen, Director, Lead for Study Management at Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”I am thrilled to share that Dr. Toby Simon and I had our article, “Source plasma apheresis and plasma-derived medicinal products: a historical review” published in the most recent issue Annals of Blood.
This paper, which can be found here, outlines the history of plasmapheresis and PDMP manufacturing which spans more than a century of scientific and clinical innovation.
We believe that understanding this history is more than academic—it underscores how continued innovation, strong regulatory oversight, and a focus on donor health are essential to sustaining a global plasma supply and advancing care for patients with immune deficiencies, coagulation disorders, and other rare diseases.”
Read the full article here.
Article: Source plasma apheresis and plasma-derived medicinal products: a historical review
Authors: Michelle Fransen, Toby Simon
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 8, 2026, 16:19Simon Senanu: Crossmatch Procedures and Advanced Troubleshooting
-
Mar 8, 2026, 15:53Stuart Diamond: ApoB as a Key Marker of Cardiovascular Risk
-
Mar 8, 2026, 15:49Wolfgang Miesbach: Discussing Immunological Challenges in Hemophilia at GTH 2026
-
Mar 8, 2026, 15:41George Sands: AI Screening Tool for Early Detection of Heart Disease
-
Mar 8, 2026, 15:26Hussien Hishmat: The 2026 Guide to Pulmonary Embolism – Diagnosis Decoded
-
Mar 8, 2026, 15:01Raluca Simbotin: How We Care for Complex Patients Is A Measure of Healthcare System Maturity
-
Mar 8, 2026, 14:09Frederik Denorme։ PhD Position in Translational Stroke Research at the University of Antwerp
-
Mar 8, 2026, 14:03Akinchan Bhardwaj: Will Plaque Imaging Eventually Reshape Preventive Cardiology Workflows?
-
Mar 8, 2026, 14:00Hisam Siddiqi: A Helpful Clinical Framework for Understanding Eosinophilia